Literature DB >> 12963128

Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer.

Satoshi Iwasa1, Xin Jin, Kyoko Okada, Masako Mitsumata, Akishi Ooi.   

Abstract

Seprase is a membrane-bound serine proteinase with gelatinase activity, which may be involved in cancer invasion and metastasis. We examined seprase expression in colorectal cancer specimens obtained from 109 patients. Seprase immunoreactivity was found in cancer cells and adjacent stromal cells. Immunoblotting showed higher levels of seprase protein in colorectal cancer tissue than in normal colorectal tissue. A semiquantitative assessment of the immunohistochemistry results revealed a significant correlation between seprase expression and lymph node metastasis. These results suggested that an abundant expression of seprase in colorectal cancer tissue is associated with lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12963128     DOI: 10.1016/s0304-3835(03)00315-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV.

Authors:  Victoria J Christiansen; Kenneth W Jackson; Kyung N Lee; Patrick A McKee
Journal:  Arch Biochem Biophys       Date:  2006-11-17       Impact factor: 4.013

2.  Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma.

Authors:  Shaojun Zhu; Yanhong Li; Li Mi; Yang Zhang; Li Zhang; Li Gong; Xiujuan Han; Li Yao; Miao Lan; Zhinan Chen; Wei Zhang
Journal:  Dig Dis Sci       Date:  2011-07-26       Impact factor: 3.199

3.  Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions.

Authors:  Yan Huang; Avis E Simms; Anna Mazur; Sophie Wang; Noel R León; Barry Jones; Nazneen Aziz; Thomas Kelly
Journal:  Clin Exp Metastasis       Date:  2011-05-22       Impact factor: 5.150

4.  Clinical implications and characteristics of factor forkhead box protein 3 in gastric cancer.

Authors:  Changli Jiang; Weihua Wang; Wei Yan; Yuhai Zhang; Jiangtao Yang; Song Zhang; Cun Zhang; Wei Zhang; Wei Han; Junzhi Wang; Ying-Qi Zhang
Journal:  Exp Ther Med       Date:  2011-05-12       Impact factor: 2.447

5.  Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion.

Authors:  Maria L Henriksson; Sofia Edin; Anna M Dahlin; Per-Arne Oldenborg; Åke Öberg; Bethany Van Guelpen; Jörgen Rutegård; Roger Stenling; Richard Palmqvist
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

6.  FOXP3 expression and clinical characteristics of hepatocellular carcinoma.

Authors:  Wei-Hua Wang; Chang-Li Jiang; Wei Yan; Yu-Hai Zhang; Jiang-Tao Yang; Cun Zhang; Bo Yan; Wei Zhang; Wei Han; Jun-Zhi Wang; Ying-Qi Zhang
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

7.  Elevation of seprase expression and promotion of an invasive phenotype by collagenous matrices in ovarian tumor cells.

Authors:  Alanna Kennedy; Huan Dong; Donghai Chen; Wen-Tien Chen
Journal:  Int J Cancer       Date:  2009-01-01       Impact factor: 7.396

8.  Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design.

Authors:  Kyung N Lee; Kenneth W Jackson; Simon Terzyan; Victoria J Christiansen; Patrick A McKee
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

9.  Transcriptional regulation of seprase in invasive melanoma cells by transforming growth factor-β signaling.

Authors:  Shaun Tulley; Wen-Tien Chen
Journal:  J Biol Chem       Date:  2014-04-13       Impact factor: 5.157

10.  FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.

Authors:  Hyung-Ok Lee; Stefanie R Mullins; Janusz Franco-Barraza; Matthildi Valianou; Edna Cukierman; Jonathan D Cheng
Journal:  BMC Cancer       Date:  2011-06-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.